ClinicalTrials.gov
ClinicalTrials.gov Menu

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00048217
Recruitment Status : Unknown
Verified July 2004 by Trimeris.
Recruitment status was:  Active, not recruiting
First Posted : October 30, 2002
Last Update Posted : June 24, 2005
Sponsor:
Information provided by:
Trimeris

October 28, 2002
October 30, 2002
June 24, 2005
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
Not Provided
Patients who complete study T1249-102 (must be currently failing a T-20 containing regimen to participate in this study) will receive T-1249 at a dose of 200mg daily in combination with a background antiretroviral regimen for 96 weeks. Only patients that participated in study T1249-102 can participate in study T1249-105.
Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Masking: None (Open Label)
Primary Purpose: Treatment
HIV Infections
Drug: T-1249
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Completion T1249-102;
  • Currently failing a T-20 containing regimen

Exclusion Criteria:

  • Non-completion of T1249-102.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00048217
T1249-105
Not Provided
Not Provided
Not Provided
Not Provided
Trimeris
Not Provided
Not Provided
Trimeris
July 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP